Cannabix Technologies Inc.
BLOZF
$0.42
$0.00320.77%
| Weiss Ratings | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.29 | |||
| Price History | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 11.79% | |||
| 30-Day Total Return | 25.37% | |||
| 60-Day Total Return | 104.88% | |||
| 90-Day Total Return | 58.49% | |||
| Year to Date Total Return | 74.20% | |||
| 1-Year Total Return | 133.33% | |||
| 2-Year Total Return | 56.42% | |||
| 3-Year Total Return | -15.80% | |||
| 5-Year Total Return | 62.41% | |||
| 52-Week High % Change | -34.70% | |||
| 52-Week Low % Change | 164.15% | |||
| Price | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.64 | |||
| 52-Week Low Price | $0.16 | |||
| 52-Week Low Price (Date) | Apr 08, 2024 | |||
| 52-Week High Price (Date) | May 17, 2024 | |||
| Valuation | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 47.77M | |||
| Enterprise Value | 45.80M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | 43.24% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 22.95 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.42 | |||
| Enterprise Value/EBITDA (TTM) | -20.90 | |||
| Enterprise Value/EBIT | -19.67 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 115.14M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 604 551 7831 | |||
| Address | 501 - 3292 Production Way Burnaby, BC V5A 4R4 | |||
| Website | cannabixtechnologies.com | |||
| Country | Canada | |||
| Year Founded | 2011 | |||
| Profitability | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -47.43% | |||
| Return on Equity | -- | |||
| Income Statement | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -2.22M | |||
| EBIT (TTM) | -2.36M | |||
| Net Income (TTM) | -2.42M | |||
| Net Income Avl. to Common (TTM) | -2.42M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 7.40% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | 6.90% | |||
| Balance Sheet | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.97M | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 2.03M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.10M | |||
| Current Ratio (Q) | 25.114 | |||
| Book Value Per Share (Q) | $0.02 | |||
| Total Assets (Q) | 2.18M | |||
| Total Current Liabilities (Q) | 80.90K | |||
| Total Debt (Q) | 34.50K | |||
| Total Liabilities (Q) | 80.90K | |||
| Total Common Equity (Q) | 2.10M | |||
| Cash Flow | BLOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -14.10K | |||
| Cash from Financing (TTM) | -124.00K | |||
| Net Change in Cash (TTM) | -1.61M | |||
| Levered Free Cash Flow (TTM) | -580.80K | |||
| Cash from Operations (TTM) | -1.48M | |||
